can you switch from semaglutide to zepbound Switching Tirzepatide Semaglutide: What to Expect Switching Your Weight Loss Injection:

Iqirvo is intended to be used in combination with ursodeoxycholic acid (UDCA) in adult patients who have an inadequate response to UDCA, or as monotherapy in patients unable to tolerate UDCA

Weight management: Individuals with a BMI of 30 or higher or 27 or higher and associated conditions such as sleep apnea, high blood pressure or high cholesterol may qualify for GLP-1 medications as part of their treatment plan

& Cao, X

Now it has become your new normal

These limitations underscore the need for large-scale randomized controlled trials with diverse patient populations and longer treatment durations to accurately assess the effects of GLP-1 RAs in the management of psoriasis

Farr et al., 2016b)